These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2574921)

  • 21. [The role of surgery in the comparison of peptic ulcer before and after the advent of H2 receptor blockers in the light of our experience].
    Pinto E; Verre L; De Stefano A; Trombì G
    Minerva Chir; 1987 Sep; 42(18):1375-82. PubMed ID: 2892149
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug therapy for preventing peptic ulcer recurrence.
    Sutherland JE
    Am Fam Physician; 1986 Nov; 34(5):141-4. PubMed ID: 2877559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E
    Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Surgical therapy in the treatment concept of ulcer disease. A critical evaluation].
    Winkeltau G; Arlt G; Treutner KH; Schumpelick V
    Leber Magen Darm; 1988 Sep; 18(5):229-35. PubMed ID: 2903423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [H2 receptor antagonists in the therapy of peptic ulcer disease].
    Dammann HG; Dau B; Dreyer M; Müller P; Simon B
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():136-45. PubMed ID: 2889298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of some antihistaminic agents on experimental peptic ulcers in cats induced with histamine and pentagastrin].
    Król W; Moczurad K; Stolfa T
    Acta Physiol Pol; 1969; 20(2):289-94. PubMed ID: 4389220
    [No Abstract]   [Full Text] [Related]  

  • 28. Review of peptic ulcer maintenance trials.
    Robinson M
    Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pro conservative long-term therapy of peptic ulcer].
    Arnold R
    Z Gastroenterol; 1984 Apr; 22(4):195-7. PubMed ID: 6145261
    [No Abstract]   [Full Text] [Related]  

  • 30. [Conservative long-term therapy of peptic ulcer--pro and con].
    Rösch W
    Z Gastroenterol; 1984 Apr; 22(4):194. PubMed ID: 6145260
    [No Abstract]   [Full Text] [Related]  

  • 31. [Retrospective study of the evaluation of peptic ulcer recurrence after 4 weeks of pirenzepin (Gastrozepin) treatment].
    Krempler F; Sandhofer F; Kalk A
    Wien Med Wochenschr; 1983 Nov; 133(21):553-7. PubMed ID: 6689235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-NSAID non-H. pylori ulcer disease.
    Chow DK; Sung JJ
    Best Pract Res Clin Gastroenterol; 2009; 23(1):3-9. PubMed ID: 19258182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
    Lanas A; Remacha B; Sáinz R; Hirschowitz BI
    Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of peptic ulcer. H2 receptor blockers].
    Domschke W
    Verh Dtsch Ges Inn Med; 1988; 94():272-5. PubMed ID: 2905101
    [No Abstract]   [Full Text] [Related]  

  • 36. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of lansoprazole in the treatment of peptic ulcers: initial healing and prevention of relapse. Tohoku Peptic Ulcer Study Group.
    Asaki S; Sato A; Sakurada H; Takeda T; Hongo M; Toyota T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S56-8. PubMed ID: 7594342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastric antisecretory and antiulcer agents.
    Bass P
    Adv Drug Res; 1974; 8():205-334. PubMed ID: 4142832
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of peptic ulcers--acid reduction or cytoprotection?
    Glise H; Carling L; Hallerbäck B; Kagevi I; Solhaug JH; Svedberg LE; Wahlby L
    Scand J Gastroenterol Suppl; 1987; 140():39-47. PubMed ID: 3328284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical treatment of peptic ulcer disease.
    Ohning G; Soll A
    Am Fam Physician; 1989 Apr; 39(4):257-70. PubMed ID: 2650509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.